C07C 223/02
Compounds containing amino and —cho groups bound to the same carbon skeleton
Official title: having amino groups bound to acyclic carbon atoms of the carbon skeleton
C07C223/02 (Compounds containing amino and —cho groups bound to the same carbon skeleton) appears on 57 US grants and 55 published applications in this corpus.
Search patents in C07C- Granted patents
- 57
- Published applications
- 55
- Assignees
- 47
- Inventors
- 147
- Latest grant
- 4 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 3 | 0 |
| 1993 | 0 | 0 |
| 1994 | 3 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 1 |
| 2003 | 2 | 1 |
| 2004 | 1 | 0 |
| 2005 | 1 | 1 |
| 2006 | 0 | 1 |
| 2007 | 2 | 1 |
| 2008 | 0 | 0 |
| 2009 | 1 | 3 |
| 2010 | 1 | 1 |
| 2011 | 0 | 5 |
| 2012 | 0 | 0 |
| 2013 | 5 | 4 |
| 2014 | 3 | 4 |
| 2015 | 1 | 5 |
| 2016 | 2 | 4 |
| 2017 | 6 | 4 |
| 2018 | 5 | 6 |
| 2019 | 1 | 3 |
| 2020 | 4 | 4 |
| 2021 | 0 | 1 |
| 2022 | 2 | 3 |
| 2023 | 3 | 1 |
| 2024 | 1 | 0 |
| 2025 | 2 | 1 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- 3-(5-chloro-2-oxobenzo[d]oxazol-3(2H)-yl) propanoic acid derivatives as KMO inhibitors4 Nov 2025US 12,459,906 B2Dr. Falk Pharma GmbH
- Substituted piperazines as disrupters of AB42 oligomer formation27 May 2025US 12,312,296 B2Acelot, Inc.
- PEG lipids and uses thereof26 Nov 2024US 12,151,029 B2ModernaTX, Inc.
- Substituted amines as disrupters of ABETA42 oligomer formation28 Nov 2023US 11,827,582 B2Acelot, Inc.
- Compound having PD-L1 inhibitory activity, preparation method therefor and use thereof17 Oct 2023US 11,787,766 B2Shanghai Ennovabio Pharmaceuticals Co., Ltd.
- Small molecule drugs and related methods for treatment of diseases related to ab42 oligomer formation25 Jun 2026US 2026/0176230 A1Acelot, Inc.
- Peg lipids and uses thereof15 May 2025US 2025/0152518 A1ModernaTX, Inc.
- Small Molecule Drugs and Related Methods for Treatment of Diseases Related to Abeta42 Oligomer Formation19 Oct 2023US 2023/0331658 A1Acelot, Inc.
- 3-(5-chloro-2-oxobenzo[d]oxazol-3(2h)-yl) propanoic acid derivatives as kmo inhibitors22 Sep 2022US 2022/0298125 A1The University Court of the University of Edinburgh
- A process for the preparation of enantiomerically pure norepinephrine24 Mar 2022US 2022/0089520 A1Edmond Pharma s.r.l.
Most cited
By later US patents
- Processes for the synthesis of 3-(substituted indolyl-2-yl)propenaldehydes25US 5,290,946 ASandoz Ltd. · 1994
- Enzymatic conjugation of antibodies23US 9,764,038 B2Innate Pharma · 2017
- 2-aminopropane-1,3-diol compounds, medicinal use thereof, and intermediates in synthesizing the same19US 6,214,873 B1Welfide Corporation · 2001
- Use of oxidized polyamines, especially NN'-bis-(3-propionaldehyde)-1-4-diaminobutane (spermine dialdehye) in graft treatment14US 5,374,658 AOrtho Phamaceutical Corporation · 1994
- Enzymatic conjugation of polypeptides13US 9,717,803 B2Innate Pharma · 2017